Atorvastatin Calcium Tablet
Product Images NDC 43598-099

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43598-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Atorvastatin Calcium Tablets, USP 10 mg by Dr. Reddy's Laboratories Inc. The label states this is for institutional use only, with a unit-dose package containing 100 tablets (10 x 10 unit-dose). The label includes warnings about child resistance and keeping the drug out of reach of children, storage instructions, and distributor information. The label features blue and pink text on a white background.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Atorvastatin Calcium Tablets, USP 20 mg, oral tablets in a unit-dose package of 100 tablets (10 unit-dose cards with 10 tablets each). Label states the product is for institutional use only, not child resistant, and to keep out of children's reach. Includes storage instructions and distributor information for Dr. Reddy's Laboratories Inc.*

FDA Label Image

Carton3 (Carton3)

Packaging label for Atorvastatin Calcium Tablets USP 40 mg, oral tablet by Dr. Reddy's Laboratories Inc. The package contains 100 tablets (10 x 10 unit-dose). The label indicates institutional use, storage instructions, and distribution details including a barcode and NDC 43598-101-78.*

FDA Label Image

Carton4 (Carton4)

Packaging label for Atorvastatin Calcium Tablets, USP 80 mg, an oral tablet by Dr. Reddy's Laboratories Inc. The label indicates a 30 tablet unit-dose package (3 blister cards of 10 tablets each). It includes usage warnings, storage instructions at 20°C to 25°C, and distributor information showing the product is made in India.*

FDA Label Image

Container1 (Container1)

Label for Atorvastatin Calcium Tablets, USP 10 mg, oral tablets by Dr. Reddy's Laboratories Inc. The package contains 90 tablets. The label includes dosage instructions, storage conditions, a barcode, a QR code for patient information, the NDC 43598-098-90, and Dr. Reddy's logo.*

FDA Label Image

Container2 (Container2)

Atorvastatin Calcium Tablets USP 20 mg oral tablets label from Dr. Reddy's Laboratories Inc. The label indicates a package of 90 film-coated tablets, provides storage instructions, dosage information, and includes a barcode and patient information QR code. The label also shows the NDC 43598-099-90.*

FDA Label Image

Container3 (Container3)

Label for Atorvastatin Calcium Tablets USP 40 mg, manufactured by Dr. Reddy's Laboratories Inc. The label indicates 90 tablets in the package, with each film-coated tablet containing atorvastatin calcium equivalent to 40 mg atorvastatin. It includes dosing and storage instructions, a QR code for patient information, an NDC number 43598-101-90, and a barcode. The product is for oral use and is prescription only.*

FDA Label Image

Container4 (Container4)

Label for Atorvastatin Calcium Tablets USP 80 mg by Dr. Reddy's Laboratories Inc. The label indicates the product contains 90 film-coated tablets for oral use. It includes dosing instructions, storage information, and a barcode. The label also provides a website and QR code for the patient information sheet. Manufactured in India.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing cumulative incidence percentages over 3.5 years for Atorvastatin and Placebo. The solid line represents Atorvastatin, showing lower cumulative incidence compared to the dashed line for Placebo. The chart includes a hazard ratio and p-value indicating statistical analysis results.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the cumulative hazard percentage over time for Atorvastatin versus placebo over a 5-year follow-up period. The x-axis represents time in years to the first primary endpoint, and the y-axis shows the cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 with confidence interval and p-value indicating statistical significance.*

FDA Label Image

Figure3 (Figure3)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years for Atorvastatin 10 mg and 80 mg tablet doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR 0.78, 95% CI 0.69-0.89) with a p-value of 0.0002, indicating statistical comparison between the two doses.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Atorvastatin Calcium, showing its molecular arrangement including phenyl groups, hydroxyl groups, and calcium ion complexation with water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.